Literature DB >> 25287589

Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).

Susan E Beekmann1, David K Henderson2.   

Abstract

Postexposure prophylaxis (PEP), which is designed to prevent human immunodeficiency virus (HIV) infection after an exposure, is one of several strategies for HIV prevention. PEP was first used after occupational HIV exposures in the late 1980s, with the Centers for Disease Control and Prevention issuing the first set of guidelines that included considerations regarding the use of antiretroviral agents for PEP after occupational HIV exposures in 1990. Use of PEP has been extended to nonoccupational exposures, including after sexual contact or injection-drug use. This article provides a rationale for PEP, assessment of the need for PEP, and details of its implementation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; HIV PEP; Nonoccupational exposure; Occupational exposure; Postexposure prophylaxis

Mesh:

Substances:

Year:  2014        PMID: 25287589      PMCID: PMC4253549          DOI: 10.1016/j.idc.2014.08.005

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  51 in total

1.  Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.

Authors:  D Rey; A L'Héritier; J M Lang
Journal:  Clin Infect Dis       Date:  2002-02-01       Impact factor: 9.079

2.  Assessing risks of human immunodeficiency virus transmission by human bite injuries.

Authors:  E Clyde Smoot; Carlos M Choucino; Margaret Z Smoot
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

3.  HIV incidence among men who have sex with men prescribed postexposure prophylaxis.

Authors:  Vincenzo Puro; Gabriella De Carli; Pierluca Piselli; Maria R Sciarrone; Elisabetta Schifano; Silvia Pittalis; Giuseppe Ippolito
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

4.  Community HIV-1 drug resistance is associated with transmitted drug resistance.

Authors:  M W Tilghman; J Pérez-Santiago; G Osorio; S J Little; D D Richman; W C Mathews; R H Haubrich; D M Smith
Journal:  HIV Med       Date:  2014-01-12       Impact factor: 3.180

5.  Postexposure treatment of HIV--taking some risks for safety's sake.

Authors:  D K Henderson
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

6.  Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.

Authors:  Shilpa M Patel; Stuart Johnson; Steven M Belknap; Juliana Chan; Beverly E Sha; Charles Bennett
Journal:  J Acquir Immune Defic Syndr       Date:  2004-02-01       Impact factor: 3.731

7.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

8.  Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis.

Authors:  D K Henderson; J L Gerberding
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

9.  Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.

Authors:  Elise M Beltrami; Chi-Cheng Luo; Nicolas de la Torre; Denise M Cardo
Journal:  Infect Control Hosp Epidemiol       Date:  2002-06       Impact factor: 3.254

10.  High-risk Sexual Behavior is Associated with Post-Exposure Prophylaxis Non-adherence among Men who have Sex with Men Enrolled in a Combination Prevention Intervention.

Authors:  Jesse B Fletcher; Joshua A Rusow; Hung Le; Raphael J Landovitz; Cathy J Reback
Journal:  J Sex Transm Dis       Date:  2013
View more
  3 in total

1.  Update on the Epidemiology and Prevention of HIV/AIDS in the United States.

Authors:  Amanda D Castel; Manya Magnus; Alan E Greenberg
Journal:  Curr Epidemiol Rep       Date:  2015-06

2.  Drug users' awareness of and willingness to use HIV non-occupational post-exposure prophylaxis (nPEP) services in China: a mixed methods study.

Authors:  Kedi Jiao; Haochu Li; Dapeng Zhang; Zhenxia Jiang; Yuxi Lin; Xueyuan Liu; Hengmin Xu; Xuemei Yan; Haoqing Tang; Wei Ma
Journal:  BMC Infect Dis       Date:  2022-02-14       Impact factor: 3.090

Review 3.  Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis.

Authors:  David J Weber; William A Rutala
Journal:  Infect Dis Clin North Am       Date:  2016-09       Impact factor: 5.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.